Clinical Trials Directory

Trials / Conditions / Relapsed or Refractory Acute Lymphoblastic Leukemia

Relapsed or Refractory Acute Lymphoblastic Leukemia

6 registered clinical trials studyying Relapsed or Refractory Acute Lymphoblastic Leukemia — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingClinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leuk
NCT06367114
Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdPhase 2
UnknownClinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Le
NCT04825496
Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdPhase 1
RecruitingClinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemi
NCT04684147
Juventas Cell Therapy Ltd.Phase 2
CompletedA Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic
NCT04230473
Juventas Cell Therapy Ltd.Phase 1
UnknownA Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL
NCT03018093
Shanghai AbelZeta Ltd.Phase 1
TerminatedVincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Ly
NCT01887587
Ehab L AtallahPhase 1